THE SHIT LIST: The Urine Culture That Prescribed Itself

The Claim

For a nonpregnant adult with no dysuria, new urgency or frequency, suprapubic pain, flank pain, fever, or haemodynamic instability, bacteriuria or pyuria alone does not establish a symptomatic urinary-tract infection. In the populations studied, treating asymptomatic bacteriuria does not improve the outcomes patients actually care about and can increase adverse effects, antibiotic exposure, resistance, and sometimes later symptomatic infection.

The claim is deliberately narrow. It is not advice to ignore a sick patient, and it does not apply to pregnancy or to an endoscopic urologic procedure expected to injure mucosa. It also does not turn the care of transplant recipients, people with spinal-cord injury, or patients with urinary devices into a parlour game. Those groups need their own rules.

The Number That Should End The Argument

In the Manitoba randomised trial, 105 women with diabetes and asymptomatic bacteriuria received antimicrobial treatment or placebo. Symptomatic urinary infection occurred in 40% of treated women and 42% of controls. Treatment-related adverse effects occurred in 18% versus 6%, and the treated group accumulated nearly five times as many antibiotic-days.

That is not a tiny victory hiding behind an inconvenient confidence interval. It is no clinical benefit bought with substantially more drug exposure. The laboratory had reported a bacterium; it had not elected it attending physician.

Why This Habit Persists

A culture result looks wonderfully definite. It supplies an organism, a colony count, and often a susceptibility table with all the confidence of a railway timetable. Symptoms are messier. People are busy. Electronic records place the red result directly under the cursor. The easiest action is to prescribe something and feel that a loose end has been tied.

The mistake often began one step earlier: ordering a urine culture without a symptom-based reason. Once the culture exists, even an honest clinician feels invited to treat it. Pyuria adds pressure, but white cells are not a diagnosis either. They can accompany colonisation, catheters, inflammation, stones, and several other conditions.

Older adults make the reflex especially tempting. Confusion or a fall may coexist with bacteriuria because both are common, not because one caused the other. The 2019 IDSA guideline recommends looking for other causes and observing carefully when delirium or a fall occurs without local urinary symptoms or systemic signs. That is active medicine, not neglect.

The Sophisticated Objection

The sensible objection is that frail patients may not describe dysuria and that delay in true sepsis is dangerous. Correct. If an older patient has fever, haemodynamic instability, rigors, flank tenderness, or another convincing systemic syndrome without a clear source, clinicians should evaluate and treat possible serious infection promptly while looking beyond the urinary tract as well.

The opposing argument also points out that the evidence is not equally modern or strong in every population. The USPSTF review found five treatment trials in 777 nonpregnant adults, mainly women and older adults, and many studies were old or incompletely reported. That limits precision. It does not manufacture a benefit that the trials failed to find.

What The Evidence Does And Does Not Say

The USPSTF concluded with moderate certainty that screening for and treating asymptomatic bacteriuria in nonpregnant adults has no net benefit. Across the five general-adult trials, treatment did not improve mortality, mobility, or symptomatic-infection rates. Established harms of antibiotics remain real even when a small trial fails to count every rash, diarrhoeal episode, drug interaction, Clostridioides difficile infection, or resistant organism.

A randomised study in young women with recurrent urinary infection went further: treating asymptomatic bacteriuria was associated with more symptomatic recurrences and more resistant organisms. That provocative result is not permission to cultivate infection. It is a reminder that not every organism detected in a stable ecosystem is an enemy requiring eviction.

Pregnancy is different. Older trials and pooled evidence show that treating screen-detected asymptomatic bacteriuria during pregnancy reduces pyelonephritis, although much of that evidence comes from an earlier clinical era. Endourologic procedures that breach mucosa are different too, because bacteriuria can seed postoperative sepsis. These are exceptions, not footnotes.

Clinical Exceptions And Safety Red Flags

Seek prompt clinical assessment for fever, rigors, new flank pain, significant pelvic or suprapubic pain, painful urination, new urinary frequency or urgency, vomiting, low blood pressure, rapid deterioration, pregnancy, or a planned invasive urologic procedure. New confusion with fever or instability is not “asymptomatic” and should not be managed by an internet article.

Do not use this article to override an individual plan for a recent kidney transplant, profound neutropenia, spinal-cord injury, chronic catheter, urinary reconstruction, or other complex urologic condition. Some of those patients present atypically, and some have evidence gaps that require specialist judgement.

What We Do About It

• Before ordering a culture, write down the symptom or clinical question it is meant to answer.
• Do not order routine urine cultures merely because urine looks cloudy, smells strong, or a dipstick shows leukocytes in an otherwise well adult.
• When a result returns positive, reassess the patient rather than treating the inbox.
• If there are no urinary or systemic symptoms, document asymptomatic bacteriuria and the relevant exception check instead of reaching automatically for antibiotics.
• If symptoms are present, diagnose and treat the actual syndrome using culture, local resistance patterns, allergies, renal function, and current guidance.
• In pregnancy or before an endourologic procedure with mucosal trauma, follow the specific screening and treatment pathway.

What Would Change My Mind

A large, modern, well-conducted randomised trial in a clearly defined nonpregnant asymptomatic population showing fewer symptomatic infections, hospitalisations, renal complications, or deaths without offsetting adverse events or resistance would change the conclusion. A prettier susceptibility table would not.

The humane point is simple: withholding an unnecessary antibiotic is not doing nothing. It is refusing to let a test result impersonate a patient.

Sources and receipts

1. IDSA 2019 Clinical Practice Guideline Update for the Management of Asymptomatic Bacteriuria — Source cited in the reviewed article
2. USPSTF Final Recommendation Statement: Asymptomatic Bacteriuria in Adults, Screening — Source cited in the reviewed article
3. USPSTF Updated Systematic Review of Screening and Treatment Evidence — Source cited in the reviewed article
4. Harding and colleagues: Antimicrobial Treatment in Diabetic Women with Asymptomatic Bacteriuria — Source cited in the reviewed article
5. Cai and colleagues: Asymptomatic Bacteriuria in Young Women with Recurrent Urinary Tract Infections — Source cited in the reviewed article
6. Abrutyn and colleagues: Treatment of Asymptomatic Bacteriuria in Older Ambulatory Women — Source cited in the reviewed article
7. Hooton and colleagues: Asymptomatic Bacteriuria and Pyuria in Premenopausal Women — Source cited in the reviewed article